Christina Annunziata
机构: Senior Vice President, American Cancer Society
每年引用次数
引用次数
引用: 8,455
H-指数: 48
I10-指数 : 100
出版物: 283
Caspase 8 expression may determine the survival of women with ovarian cancer
M Kim , L Hernandez , C M Annunziata
Cell Death and Disease 7 ( 1)
14
2016
A dual role for Caspase8 and NF-κB interactions in regulating apoptosis and necroptosis of ovarian cancer, with correlation to patient survival.
L Hernandez , , M K Kim , A M Noonan
Cell death discovery 1 ( 1) 15053 -15053
17
2015
Combination therapy: Intermittent sorafenib with bevacizumab yields activity and decreased toxicity
J-M Lee , G A Sarosy , C M Annunziata , N Azad
British Journal of Cancer 102 ( 3) 495 -499
54
2010
Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions
D H Moon , J-M Lee , A M Noonan , C M Annunziata
British Journal of Cancer 109 ( 4) 1072 -1078
42
2013
A phase II clinical trial of polyethylene glycol-conjugated L-asparaginase in patients with advanced ovarian cancer: Early closure for safety
JOHN L. HAYS , GEOFF KIM , AMANDA WALKER , CHRISTINA M. ANNUNZIATA
Molecular and Clinical Oncology 1 ( 3) 565 -569
36
2013
Recent Technological Advances in Using Mouse Models to Study Ovarian Cancer
Carrie Danielle House , Lidia Hernandez , Christina Messineo Annunziata
Frontiers in Oncology 4 26 -26
25
2014
CD40 signaling in Hodgkin's disease
Christina Messineo Annunziata
Georgetown University Medical Center
2000
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016
Andreas Lundqvist , Vincent van Hoef , Xiaonan Zhang , Erik Wennerberg
Journal for immunotherapy of cancer 4 1 -106
10
2016
We wish to thank the following reviewers for their generous assistance in evaluating manuscripts submitted to the Journal Of The National Cancer Institute during the past year.
CHRISTINA ANNUNZIATA ,
2016
http://jnci. oxfordjournals. org
CHRISTINA M ANNUNZIATA , MICHAEL J BIRRER
The Expanding Role of Proteasome-Based Therapy in the Treatment of Hematologic Malignancies
Roopa DeChowdhury , James J. Driscoll , Christina M. Annunziata , Jason Burris
Open Journal of Hematology 1 ( 1)
1
2010
Abstract TMIM-073: THE COMBINATION OF INTERFERONS ALPHA AND GAMMA AND MONOCYTES INDUCES OVARIAN CANCER CELL DEATH AND PROVIDE A RATIONALE FOR A NOVEL, ONGOING, IMMUNOTHERAPY PHASE 1 CLINICAL TRIAL
Olena Kamenyeva , Kevin W. Tosh , Chase L. Johnson , Christina M. Annunziata
Clinical Cancer Research 25
2019
Abstract A72: Dissecting the role of NF-kappaB signaling in ovarian cancer tumor-initiating cells.
Carrie D. House , Christina M. Annunziata
Clinical Cancer Research 22
2016
Abstract B43: Characterization of ovarian cancer cells as in vivo models for preclinical studies.
Lidia Hernandez , Marianne K. Kim , L Tiffany Lyle , Patricia S. Steeg
Clinical Cancer Research 22
2016
Abstract POSTER-TECH-1102: Caspase 8 cooperates with IKKβ to protect ovarian cancer cells from necroptosis
Lidia Hernandez , Anne M. Noonan , Ethan Sagher , Holger Kohlhammer
Clinical Cancer Research 21
2015
Abstract AP13: NF-KAPPAB CLASSICAL VERSUS ALTERNATIVE PATHWAYS SUPPORT DISTINCT POPULATIONS OF OVARIAN CANCER TUMOR-INITIATING CELLS
Carrie D. House , Elizabeth A. Jordan , Christina M. Annunziata
Clinical Cancer Research 23
2017
Abstract AP26: SMAC–MIMETIC TREATMENT ENHANCES ANTITUMOR EFFECT OF STANDARD CHEMOTHERAPY IN OVARIAN CANCERS EXPRESSING LOW CASPASE 8 IN VITRO AND IN VIVO
Lídia Hernandez , Christina M. Annunziata
Clinical Cancer Research 23
2017
Abstract POSTER-THER-1422: Development of proteomic biomarkers for the apoptosis pathway in ovarian cancer cell lines and determination of the appropriate sequence of the SMAC-mimetic birinapant (TL32711) and docetaxel for optimal therapeutic effect
Anne M. Noonan , Lidia Hernandez , Michelle Herrmann , Jinqui Chen
Clinical Cancer Research 21
2015
Effect of the combination of tumor necrosis factor related apoptosis inducing ligand (TRAIL) and the cyclin dependent kinase inhibitor dinaciclib on HPV+ cervical cancer cells.
David Kotlyar , Yoshimi Greer , Donna Voeller , Lidia Hernandez
Journal of Clinical Oncology 34
1
2016
Phase 1 study of intraperitoneal infusion of autologous monocytes with peginterferon alfa-2b and interferon gamma-1b in women with recurrent or refractory ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.
Ana Tablante Nunes , Daniel Green , Irene Ekwede , Kathryn Zoon
Journal of Clinical Oncology 35
2017